81 - 90 out of 1,093Page size: 10
Sort by: Title

  1. Antibodies Capable of Enhancing SARS-CoV-2 Infection Can Circulate in Patients with Severe COVID-19

    Matveev, A., Pyankov, O., Khlusevich, Y., Tyazhelkova, O., Emelyanova, L., Timofeeva, A., Shipovalov, A., Chechushkov, A., Zaitseva, N., Kudrov, G., Yusubalieva, G., Yussubaliyeva, S., Zhukova, O., Baklaushev, V., Sedykh, S., Lifshits, G., Tikunov, A. & Tikunova, N., 28 Jun 2023, In: International Journal of Molecular Sciences. 24, 13, 10799.

    Research output: Contribution to journal › Article › peer-review

  2. Antibodies from human milk hydrolyze microRNAs

    Kompaneets, I., Ermakov, E., Sedykh, S. & Nevinsky, G., Jul 2021, In: FEBS Open Bio. 11, p. 122 1 p.

    Research output: Contribution to journal › Meeting Abstract › peer-review

  3. Antibodies to highly pathogenic A/H5Nx (Clade 2.3.4.4) influenza viruses in the sera of vietnamese residents

    Ilyicheva, T., Marchenko, V., Pyankova, O., Moiseeva, A., Nhai, T. T., Lan Anh, B. T., Sau, T. K., Kuznetsov, A., Ryzhikov, A. & Maksyutov, R., Apr 2021, In: Pathogens. 10, 4, 394.

    Research output: Contribution to journal › Article › peer-review

  4. Antibody response to SARS-CoV-2 infection and Sputnik V vaccination

    Тимофеева, А. М., Седых, С. Е. & Невинский, Г. А., 2022, p. 195-195. 1 p.

    Research output: Contribution to conference › Poster › peer-review

  5. Anti-inflammatory Effects of Variola Virus TNF Decoy Receptor in an Experimental Model of Contact Dermatitis

    Viazovaia, E. A., Gileva, I. P., Toporkova, L. B., Shchelkunov, S. N. & Orlovskaya, I. A., 1 Jan 2019, In: Current Pharmaceutical Biotechnology. 19, 11, p. 910-916 7 p.

    Research output: Contribution to journal › Article › peer-review

  6. Antimetastatic Activity of Combined Topotecan and Tyrosyl-DNA Phosphodiesterase-1 Inhibitor on Modeled Lewis Lung Carcinoma

    Koldysheva, E. V., Men’shchikova, A. P., Lushnikova, E. L., Popova, N. A., Kaledin, V. I., Nikolin, V. P., Zakharenko, A. L., Luzina, O. A., Salakhutdinov, N. F. & Lavrik, O. I., 15 Mar 2019, In: Bulletin of Experimental Biology and Medicine. 166, 5, p. 661-666 6 p.

    Research output: Contribution to journal › Article › peer-review

  7. Antimetastatic Effect of Liposomal Recombinant Lactaptin

    Kaledin, V. I., Koval, O. A., Kuligina, E. V., Lushnikova, E. L., Nikolin, V. P., Popova, N. A., Pyshnaya, I. A. & Richter, V. A., Apr 2018, In: Bulletin of Experimental Biology and Medicine. 164, 6, p. 762-765 4 p.

    Research output: Contribution to journal › Article › peer-review

  8. Antitumor Activity of the Combination of Topotecan and Tyrosyl-DNA-Phosphodiesterase 1 Inhibitor on Model Krebs-2 Mouse Ascite Carcinoma

    Dyrkheeva, N. S., Zakharenko, A. L., Novoselova, E. S., Chepanova, A. A., Popova, N. A., Nikolin, V. P., Luzina, O. A., Salakhutdinov, N. F., Ryabchikova, E. I. & Lavrik, O. I., Mar 2021, In: Molecular Biology. 55, 2, p. 273-277 5 p.

    Research output: Contribution to journal › Article › peer-review

  9. Apoptosis as the basic mechanism of cytotoxic action of ursolic and pomolic acids in glioma cells

    Frolova, T. S., Lipeeva, A. V., Baev, D. S., Tsepilov, Y. A. & Sinitsyna, O. I., 1 Sept 2017, In: Molekuliarnaia biologiia. 51, 5, p. 809-816 8 p.

    Research output: Contribution to journal › Article › peer-review

  10. Apoptosis as the basic mechanism of cytotoxic action of ursolic and pomolic acids in glioma cells

    Frolova, T. S., Lipeeva, A. V., Baev, D. S., Tsepilov, Y. A. & Sinitsyna, O. I., 1 Sept 2017, In: Molecular Biology. 51, 5, p. 705-711 7 p.

    Research output: Contribution to journal › Article › peer-review

Previous 1...5 6 7 8 9 10 11 12 ...110 Next

ID: 3083609